Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety Extension of Asoprisnil in Uterine Leiomyomata
NCT00156182Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2001
- Primary completion
- Dec 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of asoprisnil in uterine leiomyoma, sponsored by Abbott Laboratories. Started Apr 2001; status: completed.
02
Drugs
asoprisnil
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT00156182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156182.